• Home
  • Research
    • Neuroblastoma Research >
      • Chromosomal copy number alterations as smoking guns for new therapeutic targets in neuroblastoma
      • Novel combination therapies targeting replication stress resistance and DNA damage repair
      • Targeted protein degradation - PROTAC development
      • ingle-cell and spatial multi-omics mapping of immunomodulatory drug responses
    • PEDIATRIC SARCOMA RESEARCH
    • Patient Avatar Models
  • Publications
  • News
  • People
  • Donate
  • Contact
My Site
  • Home
  • Research
    • Neuroblastoma Research >
      • Chromosomal copy number alterations as smoking guns for new therapeutic targets in neuroblastoma
      • Novel combination therapies targeting replication stress resistance and DNA damage repair
      • Targeted protein degradation - PROTAC development
      • ingle-cell and spatial multi-omics mapping of immunomodulatory drug responses
    • PEDIATRIC SARCOMA RESEARCH
    • Patient Avatar Models
  • Publications
  • News
  • People
  • Donate
  • Contact

Understanding 

childhood cancer 

development for
​
 
​better cures
​

 





​Illustration reproduced with permission from The Red Tree by Shaun Tan, Hachette Australia, 2001

Our mission

The PPOL team aims to identify novel druggable entry points
for pediatric solid tumors with a high unmet medical need, 
focussing particularly on neuroblastoma and sarcomas. 
To this end, we implement innovative in vitro and in vivo model 
systems combined with multi-omics read-outs. ​
Learn about our research
Catch up with PPOL
Read our publications

We are very greatful to our funders:

Picture

Pediatric Precision Oncology Lab Ghent

Understanding childhood cancer
​development for better cures


Donate

Medical Research Building (MRB), 2nd floor
Corneel Heymanslaan 10, B-9000 Ghent, Belgium
​

Tel: +32 9 332 55 33
Email: [email protected]
PPOL lab © 2024
  • Home
  • Research
    • Neuroblastoma Research >
      • Chromosomal copy number alterations as smoking guns for new therapeutic targets in neuroblastoma
      • Novel combination therapies targeting replication stress resistance and DNA damage repair
      • Targeted protein degradation - PROTAC development
      • ingle-cell and spatial multi-omics mapping of immunomodulatory drug responses
    • PEDIATRIC SARCOMA RESEARCH
    • Patient Avatar Models
  • Publications
  • News
  • People
  • Donate
  • Contact